Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2026

Balance Sheet Components [Abstract]

Summary of Available-for-sale Investments and Restricted Cash

	March 31, 2026
		Amortized		Gross Unrealized				Estimated
	Cost		Gains		Losses			Fair Value
Assets
Money market funds, included in cash equivalents	$	1,348	$	—	$	—	$	1,348
Money market funds, included in restricted cash, non-current		4,702		—		—		4,702
U.S. government securities		81,500		—		(78)		81,422
U.S. treasury bills		19,864		1		—		19,865
Corporate bonds/notes		63,517		—		(153)		63,364
Agency bonds/notes		44,137		—		(108)		44,029
Asset-backed securities		21,638		—		(25)		21,613
Commercial paper		4,935		—		(1)		4,934
Total	$	241,641	$	1	$	(365)	$	241,277
Classified as:
Cash equivalents							$	1,348
Short-term investments								138,645
Long-term investments								96,582
Restricted cash								4,702
Total							$	241,277

	December 31, 2025
		Amortized		Gross Unrealized				Estimated
	Cost		Gains		Losses			Fair Value
Assets
Money market funds, included in cash equivalents	$	27,806	$	—	$	—	$	27,806
Money market funds, included in restricted cash, non-current		4,709		—		—		4,709
U.S. government securities		81,385		94		—		81,479
U.S. treasury bills		39,568		25				39,593
Corporate bonds/notes		57,564		19		(12)		57,571
Agency bonds/notes		25,147		7		(3)		25,151
Asset-backed securities		21,689		22		—		21,711
Commercial paper		9,868		2		—		9,870
Total	$	267,736	$	169	$	(15)	$	267,890
Classified as:
Cash equivalents							$	27,806
Short-term investments								132,010
Long-term investments								103,365
Restricted cash								4,709
Total							$	267,890

Summary of Fair Value of Cash Equivalents and Available-for-sale Investments Classified by Maturity

	March 31, 2026		December 31, 2025
Amounts maturing within one year	$	139,993	$	159,816
Amounts maturing after one year through two years		96,582		103,365
Total	$	236,575	$	263,181

Schedule of Available-for-sale Investments in an Unrealized Loss Position

	March 31, 2026				December 31, 2025
	Less than 12 months				Less than 12 months
	Fair Value		Unrealized Loss		Fair Value		Unrealized Loss
Assets
U.S. government securities	$	566	$	(78)	$	—	$	—
Corporate bonds/notes		413		(153)		26,716		(12)
Agency bonds/notes		389		(108)		3,995		(3)
Asset-backed securities		47		(25)		—		—
Commercial paper		—		(1)		—		—
Total	$	1,415	$	(365)	$	30,711	$	(15)

Schedule of Allowance for Credit Loss

	March 31,		December 31,
	2026		2025
Balance at beginning of period	$	626	$	814
Additions		—		—
Write-offs		—		(188)
Balance at end of period	$	626	$	626

Summary of Prepaid Expenses and Other Current Assets

	March 31,		December 31,
	2026		2025
Prepaid expenses	$	8,313	$	5,964
Contract costs, current		8,202		6,669
Other		1,472		1,442
Total prepaid expenses and other current assets	$	17,987	$	14,075

Schedule of Property and Equipment, Net

	March 31,		December 31,
	2026		2025
Property and equipment at cost:
Computer equipment and software	$	4,277	$	4,223
Furniture, fixtures and equipment		2,280		2,114
Capitalized internal-use software		13,624		12,529
Leasehold improvements		2,095		2,086
Construction in progress		1,481		140
Total property and equipment		23,757		21,092
Less: Accumulated depreciation and amortization		(13,928)		(12,505)
Property and equipment, net	$	9,829	$	8,587

Schedule of Other Non-Current Assets

	March 31,		December 31,
	2026		2025
Contract costs, net	$	5,071	$	4,260
Other		1,604		839
Total other non-current assets	$	6,675	$	5,099

Schedule of Accrued Expenses and Other Current Liabilities

	March 31,		December 31,
	2026		2025
Accrued payroll and related expenses	$	19,762	$	28,150
Customer contract and rebate liabilities		1,583		1,162
Accrued royalty		1,049		864
Accrued professional fees		821		627
Accrued clinical trial expenses		1,118		550
Other		1,553		1,926
	$	25,886	$	33,279